Press Release
In this press release page you can find a selection of the main articles about Anemocyte
published by newspapers and magazines, both online and on paper.
2019
- 08/05/2019 – “Terapie avanzate, così l’Italia si candida al ruolo di hub internazionale” – Sanità 24 – Il Sole 24 ore
- 11/02/2019 – “Nella fabbrica delle molecole ho un principio:arginare pechino” – Il Corriere della Sera
2020
- 17/02/2020 – “La medicina del futuro è bio e “su misura”” – Economy mag
- 17/02/2020 – “Tackling the plasmid supply bottleneck” – Bio Insights
- 02/02/2020 – “How Anemocyte is Changing History as a Biotech Manufacturing Organization (BMO)” – Bioinformant
- 23/01/2020 – “Anemocyte Brings Italian Excellence in the Cell and Gene Therapy Sector to Phacilitate Leaders World 2020 in Miami” – Biospace
2019
- 25/11/2019 – “Critical needs and challenges for the cell and gene therapy raw materials supply chain” – Bio Insights
- 25/11/2019 – “Critical needs and challenges for the cell and gene therapy raw materials supply chain” – Bio Insights
- 28/10/2019 – “Riva del Garda: al via la XX Convention Scientifica di Fondazione Telethon” – Telethon
- 12/10/2019 – “Malattie rare. “Milasen”: negli Usa il primo farmaco creato apposta per un solo paziente” – Quotidiano Sanità
- 10/10/2019 – “L’italiano da 20 miliardi che vuole battere il cancro” – Il Giornale
- 12/09/2019 – “Genenta Science ha raccolto 30 milioni di euro per combattere i tumori con il trasferimento genico” – Wired
- 11/09/2019 – “Italian Biotech Raises €13M to Test Stem Cell Therapy for Cancer” – Labiothech
- 05/07/2019 – “Drones Land in the Cell and Gene Therapy Space” – GEN
- 25/06/2019 – “Technology Review: Gene Editing” – Phacilitate
- 20/06/2019 – “The Power of Perseverance: How Dendreon Bounced Back” – Phacilitate
- 19/06/2019 – “Cell and Gene Therapy (CGT) Manufacturing Boom Roars Along” – BioInformant
- 03/06/2019 – “Perché fa sempre notizia il costo delle terapie per le malattie rare” – Huffpost
- 03/06/2019 – “Bluebird Bio’s First Gene Therapy Wins Approval in Europe” – Bloomberg
- 27/05/2019 – “Meet the World’s First Biotech Manufacturing Organization, BMO” – Labiotech
- 27/05/2019 – “Manufacturing Advanced Therapies in Europe” – Phacilitate
- 25/01/2019 – “Excellula, il Nuovo Centro per le Terapie Avanzate” – Wired
- 29/01/2019 – “Cell and Gene Therapies” – BioInformat
- 08/02/2019 – “Il Centro per le Turbo-terapie” – La Stampa